Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle

NORBIMATOPROST.

Avoid

Norbimatoprost is a synthetic prostaglandin analog, structurally derived from bimatoprost and related to natural prostaglandin F2α. It is primarily researched for its potential to stimulate hair growth, particularly in areas like eyelashes and eyebrows.

Hair Growth Promoter

Science

Operating as a prostamide analog, Norbimatoprost is inferred to activate specific prostamide receptors, distinct from F prostanoid receptors. This activation is believed to extend the anagen (growth) phase of the hair cycle and increase hair follicle size, contributing to enhanced hair growth.


Research

Low confidence
Effective range 0.0008–0.027%
Optimal

N/A


Transparency

Commonly dusted
Min. effective
1e-8%
Red flag below
1e-8%

The Scientific Committee on Consumer Safety (SCCS) of the European Commission concluded that Norbimatoprost, along with other prostaglandin analogues, 'cannot be considered safe for use in cosmetic products' due to its potent pharmacological activity at low concentrations and a lack of sufficient data to exclude potential adverse effects, including reproductive/developmental toxicity. The FDA typically views ingredients that induce physiological changes, such as hair growth, as drugs rather than cosmetics, regardless of marketing claims.


The Formula

Solubility
Oil
Optimal pH N/A
0 7 14

Stability

N-Norbimatoprost is recommended to be stored at -20°C for maximum product recovery, suggesting thermal sensitivity. While direct stability data for Norbimatoprost is limited, its parent compound, bimatoprost, shows stability at 4°C and 25°C but degrades at higher temperatures (50°C and 70°C).


Safety

CIR Status
Not reviewed (The CIR Expert Panel has discussed prostaglandin analogues, including Norbimatoprost, but has not issued a definitive 'safe as used' or 'safe with restrictions' status for Norbimatoprost specifically)
Pregnancy
Caution
Sensitization risk Moderate

Norbimatoprost, as a prostaglandin analog, carries significant safety concerns. The SCCS of the European Commission explicitly concluded in 2025 that it 'cannot be considered safe for use in cosmetic products' due to its potent pharmacological activity and insufficient comprehensive safety data, including concerns regarding reproductive/developmental toxicity. While its parent compound, bimatoprost (Latisse), is an FDA-approved prescription drug for eyelash growth, Norbimatoprost lacks specific FDA approval for cosmetic use.


Your Skin

No Normal
No Dry
No Oily
No Sensitive
Irritancy Moderate
Comedogenicity Unknown

Our Assessment

Avoid

Given the explicit conclusion by the European Commission's SCCS that Norbimatoprost 'cannot be considered safe for use in cosmetic products' due to its potent pharmacological activity and insufficient safety data, this ingredient is strongly advised against.


Related

Finding similar ingredients…